BioForce to Collaborate on Food Pathogen Detection
The primary investigator on the project is Dr. Byron Brehm-Stecher, a faculty member in the department of Food Science and Human Nutrition at ISU where the pathogen related work will be performed. The focus of his research is to provide new tools for the rapid and label-free detection of pathogen specific nucleic acid sequences with the potential to benefit the food industry, the medical and environmental diagnostics industries and the biotechnology and biodefense sectors.
Dr. Saju Nettikadan, Director of the Research and Application Development group at BioForce will be a key researcher on this project. Dr. Nettikadan noted that "The NanoArrayer(TM) System technology developed by BioForce will provide a way to deposit the biomolecules used to capture the amplified pathogen DNA onto very small chip surfaces prior to detection. The primary advantage of this combined new assay platform is the potential for faster reaction kinetics which translates to shorter timeframes to detection and the ability to detect a variety of pathogens on a single chip. The experience we garnered in the development of our patented ViriChip(TM) product will greatly enhance the proposed research."
Dr. Eric Henderson, Founder and CEO of BioForce Nanosciences, is co-principal investigator on this funded grant. "This project will focus on the combination of nanotechnology and molecular biology to create a new and powerful platform for pathogen detection in foods. Success of this project has the potential to positively affect NanoArrayer System sales. In addition, the use of atomic force microscopy (AFM) for detection provides a unique approach for the development of label-free, nanotechnology-based molecular diagnostics. BioForce has over a decade of experience utilizing the AFM in the field of bionanotechnology research and in retail marketing of a line of AFM support products."
About BioForce Nanosciences
BioForce Nanosciences, Inc. has patented and patent-pending technology and products for ultramicro- and nanoscale placement and patterning of active biomolecules and other materials. This technology is embodied in the NanoArrayer(TM) System, a proprietary instrumentation/software platform. As an industry leader in the emerging field of bionanotechnology, BioForce Nanosciences is focused on providing practical molecular printing tools to the biomedical and life sciences markets. The company currently offers a line of accessory products for atomic force microscopy and new innovative products as a cornerstone of the company.